What is the appropriate dosing of N-acetylcysteine (NAC) for a 68kg patient with a suspected acetaminophen overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-Acetylcysteine Dosing for 68kg Patient with Suspected Acetaminophen Overdose

Administer N-acetylcysteine using the standard weight-based intravenous protocol: 150 mg/kg (10,200 mg) loading dose over 15 minutes, followed by 50 mg/kg (3,400 mg) over 4 hours, then 100 mg/kg (6,800 mg) over 16 hours—for a total dose of 300 mg/kg (20,400 mg) over 21 hours. 1, 2, 3

Immediate Administration Protocol

Start NAC immediately without waiting for acetaminophen levels if there is strong clinical suspicion of significant overdose, as treatment efficacy is critically time-dependent. 1, 2

Intravenous Dosing Regimen (Preferred)

For your 68kg patient, calculate the exact doses as follows:

  • Loading dose: 150 mg/kg = 10,200 mg diluted in 200 mL of 5% dextrose, infused over 15 minutes 1, 2, 3
  • Second dose: 50 mg/kg = 3,400 mg diluted in 500 mL of 5% dextrose, infused over 4 hours 1, 2, 3
  • Third dose: 100 mg/kg = 6,800 mg diluted in 1000 mL of 5% dextrose, infused over 16 hours 1, 2, 3

Total treatment duration: 21 hours 1, 2, 3

Alternative Oral Dosing (If IV Not Available)

  • Loading dose: 140 mg/kg = 9,520 mg orally or via nasogastric tube, diluted to 5% solution 1, 2
  • Maintenance doses: 70 mg/kg = 4,760 mg every 4 hours for 17 additional doses (total 72 hours) 1, 2

The 72-hour oral regimen is as effective as the 20-hour IV regimen and may be superior when treatment is delayed. 1

Critical Timing Considerations

The window for maximal efficacy is 0-8 hours post-ingestion, where NAC provides the greatest hepatoprotection with only 2.9% developing severe hepatotoxicity. 1, 2

  • Within 8 hours: 2.9% risk of severe hepatotoxicity 1, 2
  • Within 10 hours: 6.1% risk of severe hepatotoxicity 1
  • After 10 hours: 26.4% risk of severe hepatotoxicity 1

However, NAC should never be withheld even in late presentations (>24 hours), as it still reduces mortality from 80% to 52% in fulminant hepatic failure regardless of time since ingestion. 1, 2

Adjunctive Measures

If the patient presents within 4 hours of ingestion, administer activated charcoal (1 g/kg = 68 grams) just prior to starting NAC. 1, 2 Do not delay NAC administration even if activated charcoal has been given. 2

When to Extend Treatment Beyond 21 Hours

Continue NAC beyond the standard 21-hour protocol if any of the following apply:

  • Acetaminophen levels remain detectable at 21 hours 1, 3
  • ALT/AST continue rising or remain elevated 1, 3
  • INR remains elevated 1, 3
  • Delayed presentation (>24 hours post-ingestion) 1, 2
  • Extended-release acetaminophen formulation 1, 2
  • Repeated supratherapeutic ingestions 1, 2
  • Unknown time of ingestion with detectable levels 1, 2
  • Massive overdose (acetaminophen concentration above the "300-line" on nomogram) 1, 4

For massive overdoses with concentrations above the 300-line, consider step-wise increases in NAC dosing at the 300-, 450-, and 600-lines on the nomogram. 1, 4

Monitoring Requirements

Obtain the following labs before starting NAC and serially throughout treatment:

  • Acetaminophen level (4-24 hours post-ingestion for nomogram use) 1, 2
  • AST, ALT, bilirubin 1, 2, 3
  • INR/PT 1, 2, 3
  • Creatinine, BUN 2, 3
  • Blood glucose, electrolytes 2, 3

Recheck labs at 12 hours and 21 hours to determine if treatment can be safely discontinued. 1, 3, 5

Special Populations Requiring Lower Treatment Threshold

Treat with NAC even if acetaminophen levels are in the "non-toxic" range for:

  • Chronic alcohol users (hepatotoxicity can occur with doses as low as 4 g/day) 1, 2
  • Fasting patients 2
  • Patients taking enzyme-inducing drugs 1

Critical Safety Considerations

Monitor closely for hypersensitivity reactions, especially during the loading dose, as serious acute reactions including rash, hypotension, wheezing, and bronchospasm can occur. 3 If severe hypersensitivity occurs, immediately stop the infusion and initiate appropriate treatment. 3

Use with extreme caution in patients with asthma, as one patient with asthma developed fatal bronchospasm after IV NAC administration. 3

Acute flushing and erythema typically occur 30-60 minutes after initiating infusion and often resolve spontaneously despite continued infusion. 3 If the reaction involves more than simple flushing, treat as hypersensitivity with temporary interruption and/or antihistamines. 3

When NAC Can Be Safely Discontinued

NAC can be discontinued after 21 hours ONLY if ALL of the following criteria are met:

  • Acetaminophen level is undetectable 1, 3
  • AST and ALT remain normal (no elevation above baseline) 1, 3
  • INR is normal 1, 3
  • Patient presented early (<24 hours) with single acute ingestion 1

In carefully selected very low-risk patients with normal labs at presentation and 12 hours, a 12-hour NAC course may be safe, but this requires careful consideration. 1, 5

Common Pitfalls to Avoid

  • Do not use the Rumack-Matthew nomogram for presentations >24 hours post-ingestion—base treatment decisions on acetaminophen levels and liver function tests instead. 1
  • Do not delay NAC while awaiting confirmatory levels if there is strong suspicion of significant overdose. 2
  • Low or absent acetaminophen levels do NOT rule out acetaminophen poisoning if ingestion was remote or occurred over several days. 1
  • Do not use a maximum weight cutoff—use actual weight-based dosing even for patients >100 kg. 6
  • For repeated supratherapeutic ingestions, the nomogram does not apply—treat if acetaminophen ≥10 mg/mL or if AST/ALT >50 IU/L. 1, 3

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.